Get started
Author

Adrián Arés Luque

Observed names: A Arés Luque, A Luque, A. Ares Luque, A. Arés Luque, A. Arés luque, Adrian Ares Luque, Adrián Ares, Adrián Ares Luque, Adrián Arés
ORCID: 0000-0001-5193-3001
Observed ORCID: 0000-0001-5193-3001
OpenAlex ID: A5069357027
Hashimoto's Encephalopathy
2019 · A Arés Luque, M D Ballesteros Pomar, et al. · Advances in medical diagnosis, treatment, and care (AMDTC) book series · 41
Expert-Agreed Practical Recommendations on the Use of Cladribine
2022 · Virginia Meca-Lallana, José M. García Domínguez, et al. · Neurology and Therapy · 29
Documento de consenso de la Sociedad Española de Neurología sobre el tratamiento de la esclerosis múltiple y manejo holístico del paciente 2023
2024 · J.E. Meca-Lallana, S. Martínez Yélamos, et al. · Neurología · 18
Consensus statement of the Spanish Society of Neurology on the treatment of multiple sclerosis and holistic patient management in 2023
2024 · J.E. Meca-Lallana, S. Martínez Yélamos, et al. · Neurología (English Edition) · 13
Nutrición basada en la evidencia en las enfermedades neurológicas
2005 · M.D. Ballesteros pomar, A. Arés luque · Endocrinología y Nutrición · 8
Effectiveness and Safety of Teriflunomide in Relapsing–Remitting Multiple Sclerosis and Improvements in Quality of Life: Results from the Real-World TERICARE Study
2023 · José E. Meca-Lallana, José M. Prieto González, et al. · Neurology and Therapy · 6
PDF
Disease modifying therapy switching in relapsing multiple sclerosis: A Delphi consensus of the demyelinating expert group of the Spanish society of neurology
2022 · Luis Brieva, Bonaventura Casanova Estruch, et al. · Multiple Sclerosis and Related Disorders · 6
Actualización en coreas
2009 · Fernando Vázquez Sánchez, Elena Rodríguez Martínez, et al. · Revista de Neurología · 4
Trastornos urinarios, disfunción sexual e hipersexualidad en la enfermedad de Parkinson
2010 · Fernando Vázquez Sánchez, Elena Rodríguez Martínez, et al. · Revista de Neurología · 2
Irritable bowel syndrome: attrition rates of patients identified at primary care centers during a 50-week period versus those identified in hospitals in a phase II clinical trial.
2001 · R Dal-Ré, A Luque, et al. · PubMed · 2
Neurologists’ decision-making in the management of generalised myasthenia gravis: Therapeutic inertia and treatment choices
2026 · Gerardo Gutiérrez-Gutiérrez, Rocío Gómez-Ballesteros, et al. · Journal of Neuromuscular Diseases · 1
Severe Reactivation of Rheumatic Cardiopathy During Treatment with Ocrelizumab. (2111)
2020 · Luis Hernández-Echebarría, Adrian Ares Luque, et al. · Neurology · 1
Clinical repercussions of dysphagia and malnutrition in the stroke patient
2018 · Paula Fernández Martínez, David E. Barajas Galindo, et al. · Endocrinología Diabetes y Nutrición (English ed ) · 1
Repercusiones clínicas de la disfagia y la desnutrición en el paciente con ictus
2018 · Paula Fernández Martínez, David E. Barajas Galindo, et al. · Endocrinología Diabetes y Nutrición · 1
Emergencias en trastornos del movimiento hipercinéticos
2012 · Laura Redondo Robles, A. Galiana Ivars, et al. · Revista de Neurología · 1
XVIII Post-ECTRIMS Meeting: Review of the New Developments Presented at the 2025 ECTRIMS Congress (Part II)
2026 · Óscar Fernández, Xavier Montalban, et al. · Revista de Neurología
PDF
XVIII Post-ECTRIMS Meeting: Review of the New Developments Presented at the 2025 ECTRIMS Congress (Part I)
2026 · Óscar Fernández, Xavier Montalban, et al. · Revista de Neurología
PDF
Real-world siponimod use in secondary progressive multiple sclerosis: the RESYZE study
2026 · Celia Oreja-Guevara, Irene Gómez-Estévez, et al. · Therapeutic Advances in Neurological Disorders
XVII Post-ECTRIMS Meeting: Review of the New Developments Presented at the 2024 ECTRIMS Congress (I)
2026 · Óscar Fernández, Adrián Arés, et al. · Revista de Neurología
PDF
XVII Post-ECTRIMS Meeting: Review of the New Developments Presented at the 2024 ECTRIMS Congress (II)
2026 · Óscar Fernández, Adrián Arés, et al. · Revista de Neurología
HSD80 Organizational Support in Adopting New Treatments for Generalized Myasthenia Gravis
2025 · Thaís Armangué, Rocío Gómez-Ballesteros, et al. · Value in Health
Resistance to change in adopting new targeted treatments for generalized myasthenia gravis
2025 · Javier Sotoca, Rocío Gómez-Ballesteros, et al. · Journal of the Neurological Sciences
20415. Uso De Siponimod En Pacientes Con Esclerosis Múltiple Secundaria Progresiva En Práctica Clínica. Estudio Resyze
2024 · M. Díaz Sánchez, I. Gómez-Estévez, et al. · Neurology Perspectives
Multiple Sclerosis Treatment and Holistic Patient Care Consensus by the Spanish Society of Neurology (P3-6.013)
2024 · José E. Meca Lallana, Sergio Martínez Yélamos, et al. · Neurology
Homozygosis variant p.asn115* in the ANO10 gene: a new discovered cause of spinocerebellar Ataxia
2022 · Iria Beltrán Rodríguez, Adrián Arés Luque, et al. · International Physical Medicine & Rehabilitation Journal
PDF
Works count: 29
Citation count: 134
H-index: 6
I10-index: 4
Year
Topic
Type